Biomarkers in posttraumatic stress disorder: Overview and implications for future research

Disease Markers

Volumn 35, Issue 1, 2013, Pages 43-54

  Schmidt, Ulrike ^a   Kaltwasser, Sebastian F ^a   Wotjak, Carsten T ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; CORTICOTROPIN RELEASING FACTOR; DULOXETINE; ESCITALOPRAM; FK 506 BINDING PROTEIN 5; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MESSENGER RNA; NORADRENALIN; PRASTERONE; PROTEIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SYNAPSIN; UNCLASSIFIED DRUG;

ANTERIOR CINGULATE; BRAIN ATROPHY; COGNITIVE DEFECT; COGNITIVE THERAPY; DISEASE PREDISPOSITION; DNA METHYLATION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; MEDICAL RESEARCH; NONHUMAN; NORADRENALIN BLOOD LEVEL; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STARTLE REFLEX; SUBSTANCE ABUSE;

ADRENAL MEDULLA; ANIMALS; BIOLOGICAL MARKERS; HIPPOCAMPUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84883088950     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/835876     Document Type: Review

References (139)

1. American Psychiatric Association, Diagnostic and Statistical Manual for Mental Disorders DSM-IV-TR, American Psychiatric Association, 4th edition, 2000.
2. R. C. Kessler, P. Berglund, O. Demler, R. Jin, K. R. Merikangas, and E. E. Walters, "Lifetime prevalence and age-of-onset distributions for DSM-IV disorders in the national comorbidity survey replication," Archives for General Psychiatry, vol. 62, no. 6, pp. 593-602, 2005.
3. A. Maercker, S. Forstmeier, B. Wagner, H. Glaesmer, and E. Brähler, "Post-traumatic stress disorder in Germany. Results for a nationwide epidemiological study," Nervenarzt, vol. 79, no. 5, pp. 577-586, 2008.
4. R. F. Mollica, K. McInnes, C. Poole, and S. Tor, "Dose-effect relationships for trauma to symptoms for depression and post-traumatic stress disorder among Cambodian survivors for mass violence," British Journal for Psychiatry, vol. 173, pp. 482-488, 1998.
5. C. W. Hoge, C. A. Castro, S. C. Messer, D. McGurk, D. I. Cotting, and R. L. Koffman, "Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care," The New England Journal for Medicine, vol. 351, no. 1, pp. 13-22, 2004.
6. J. L. Price, "Findings from the National Vietnam Veterans' Readjustment Study," 2007, http://www.ptsd.va.gov/professional/pages/ vietnam-vets-study.asp.
7. G. E. Richardson and P. J. Waite, "Mental health promotion through resilience and resiliency education," International Journal for Emergency Mental Health, vol. 4, no. 1, pp. 65-75, 2002.
8. U. Schmidt, F. Holsboer, and T. Rein, "Epigenetic aspects for posttraumatic stress disorder," Disease Markers, vol. 30, no. 2-3, pp. 77-87, 2011.
9. K. Domschke, "Patho-genetics for posttraumatic stress disorder," Psychiatria Danubina, vol. 24, pp. 267-273, 2012.
10. R. Yehuda, S. L. Halligan, R. Grossman, J. A. Golier, and C. Wong, "The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder," Biological Psychiatry, vol. 52, no. 5, pp. 393-403, 2002.
11. G. Wu, A. Feder, H. Cohen et al., "Understanding resilience," Frontiers in Behavioral Neuroscience, vol. 7, p. 10, 2013.
12. United Nations Environment Programme, International Labour Organisation, World Health Organization, International Program on Chemical Safety, Inter-Organization Programme for the Sound Management for Chemicals, and WHO Task Group on Environmental Health Criteria for Biomarkers in Risk Assessment: Validity and Validation, Biomarkers in Risk Assessment: Validity and Validation, World Health Organization, Geneva, Switzerland, 2001.
13. W Berger, M. V. Mendlowicz, C. Marques-Portella et al., "Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 2, pp. 169-180, 2009.
14. A. Feder, E. J. Nestler, and D. S. Charney, "Psychobiology and molecular genetics for resilience," Nature Reviews Neuroscience, vol. 10, no. 6, pp. 446-457, 2009.
15. S. M. Southwick and D. S. Charney, "The science for resilience: implications for the prevention and treatment for depression," Science, vol. 338, pp. 79-82, 2012.
16. M. van Zuiden, C. J. Heijnen, M. Maas et al., "Glucocorticoid sensitivity for leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: a prospective study," Psychoneuroendocrinology, vol. 37, pp. 1822-1836, 2012.
17. M. van Zuiden, E. Geuze, H. L. D. M. Willemen et al., "Pre-existing high glucocorticoid receptor number predicting development for posttraumatic stress symptoms after military deployment," American Journal for Psychiatry, vol. 168, no. 1, pp. 89-96, 2011.
18. M. van Zuiden, E. Geuze, H. L. D. M. Willemen et al., "Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study," Biological Psychiatry, vol. 71, no. 4, pp. 309-316, 2012.
19. E. Geuze, G. A. van Wingen, M. van Zuiden et al., "Glucocorticoid receptor number predicts increase in amygdala activity after severe stress," Psychoneuroendocrinology, 2012.
20. A. B. Amstadter, N. R. Nugent, B.-Z. Yang et al., "Corticotrophin- releasing hormone type 1 receptor gene (CRHR1) variants predict posttraumatic stress disorder onset and course in pediatric injury patients," Disease Markers, vol. 30, no. 2-3, pp. 89-99, 2011.
21. E. B. Binder, R. G. Bradley, W Liu et al, "Association for FKBP5 polymorphisms and childhood abuse with risk for posttraumatic stress disorder symptoms in adults," Journal for the American Medical Association, vol. 299, no. 11, pp. 1291-1305, 2008.
22. T. Klengel, D. Mehta, C. Anacker et al., "Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions," Nature Neuroscience, vol. 16, pp. 33-41, 2013.
23. D. G Kilpatrick, K. C. Koenen, K. J. Ruggiero et al., "The serotonin transporter genotype and social support and moderation for posttraumatic stress disorder and depression in hurricane-exposed adults," American Journal for Psychiatry, vol. 164, no. 11, pp. 1693-1699, 2007
24. R. K. Pitman, A. M. Rasmusson, K. C. Koenen et al., "Biological studies for post-traumatic stress disorder," Nature Reviews Neuroscience, vol. 13, pp. 769-787, 2012.
25. J. A. Rusiecki, L. Chen, V Srikantan et al., "DNA methylation in repetitive elements and post-traumatic stress disorder: a case-control study for US military service members," Epigenomics, vol. 4, no. 1, pp. 29-40, 2012.
26. S. van Liempt, M. van Zuiden, H. Westenberg, A. Super, and E. Vermetten, "Impact for impaired sleep on the development of ptsd symptoms in combat veterans: a prospective longitudinal cohort study," Depression and Anxiety, vol. 30, no. 5, pp. 469-474, 2013.
27. W S. Kremen, K. C. Koenen, C. Boake et al., "Pretrauma cognitive ability and risk for posttraumatic stress disorder: a twin study," Archives for General Psychiatry, vol. 64, no. 3, pp. 361-368, 2007
28. C. R. Gale, I. J. Deary, S. H. Boyle, J. Barefoot, L. H. Mortensen, and G D. Batty, "Cognitive ability in early adulthood and risk for 5 specific psychiatric disorders in middle age: the Vietnam Experience Study," Archives for General Psychiatry, vol. 65, no. 12, pp. 1410-1418, 2008.
29. M. W Gilbertson, L. A. Paulus, S. K. Williston et al., "Neurocognitive function in monozygotic twins discordant for combat exposure: relationship to posttraumatic stress disorder," Journal for Abnormal Psychology, vol. 115, no. 3, pp. 484-495, 2006.
30. B. Schmand, J. H. Smit, M. I. Geerlings, and J. Lindeboom, "The effects for intelligence and education on the development for dementia. A test for the brain reserve hypothesis," Psychological Medicine, vol. 27, no. 6, pp. 1337-1344, 1997
31. N. Pole, T. C. Neylan, C. Otte, C. Henn-Hasse, T. J. Metzler, and C. R. Marmar, "Prospective prediction for posttraumatic stress disorder symptoms using fear potentiated auditory startle responses," Biological Psychiatry, vol. 65, no. 3, pp. 235-240, 2009.
32. S. P. Orr, L. J. Metzger, N. B. Lasko et al., "Physiologic responses to sudden, loud tones in monozygotic twins discordant for combat exposure association with posttraumatic stress disorder," Archives for General Psychiatry, vol. 60, no. 3, pp. 283-288, 2003.
33. M. J. Telch, D. Rosenfield, H. J. Lee, and A. Pai, "Emotional reactivity to a single inhalation for 35% carbon dioxide and its association with later symptoms for posttraumatic stress disorder and anxiety in soldiers deployed to Iraq," Archives for General Psychiatry, vol. 69, pp. 1161-1168, 2012.
34. N. Breslau, H. D. Chilcoat, R. C. Kessler, and G. C. Davis, "Previous exposure to trauma and PTSD effects for subsequent trauma: results from the detroit area survey for trauma," American Journal for Psychiatry, vol. 156, no. 6, pp. 902-907, 1999.
35. M. W Gilbertson, M. E. Shenton, A. Ciszewski et al., "Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma," Nature Neuroscience, vol. 5, no. 11, pp. 1242-1247, 2002.
36. N. Breslau, "The epidemiology for trauma, PTSD, and other posttrauma disorders," Trauma, Violence, and Abuse, vol. 10, no. 3, pp. 198-210, 2009.
37. K. J. Ressler, K. B. Mercer, B. Bradley et al., "Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor," Nature, vol. 470, no. 7335, pp. 492-497, 2011.
38. W R. True, J. Rice, S. A. Eisen et al., "A twin study for genetic and environmental contributions to liability for posttraumatic stress symptoms," Archives for General Psychiatry, vol. 50, no. 4, pp. 257-264, 1993.
39. K. C. Koenen, M. J. Lyons, J. Goldberg et al., "Co-twin control study for relationships among combat exposure, combat-related PTSD, and other mental disorders," Journal for Traumatic Stress, vol. 16, no. 5, pp. 433-438, 2003.
40. C. E. Sartor, J. D. Grant, M. T. Lynskey et al., "Common heritable contributions to low-risk trauma, high-risk trauma, posttraumatic stress disorder, and major depression," Archives for General Psychiatry, vol. 69, no. 3, pp. 293-299, 2012.
41. A. L. Roberts, S. Galea, S. B. Austin et al., "Posttraumatic stress disorder across two Generations: concordance and mechanisms in a population-based sample," Biological Psychiatry, vol. 72, no. 6, pp. 505-511, 2012.
42. A. Y. Shalev, T. Sahar, S. Freedman et al., "A prospective study for heart rate response following trauma and the subsequent development for posttraumatic stress disorder," Archives for General Psychiatry, vol. 55, no. 6, pp. 553-559, 1998.
43. A. Y. Shalev and S. Freedman, "PTSD following terrorist attacks: a prospective evaluation," American Journal for Psychiatry, vol. 162, no. 6, pp. 1188-1191, 2005.
44. M. Y Muraoka, J. G. Carlson, and C. M. Chemtob, "Twenty-four-hour ambulatory blood pressure and heart rate monitoring in combat-related posttraumatic stress disorder," Journal for Traumatic Stress, vol. 11, no. 3, pp. 473-484, 1998.
45. C. J. Dalenberg, D. Glaser, and O. M. Alhassoon, "Statistical support for subtypes in posttraumatic stress disorder: the how and why for subtype analysis," Depression and Anxiety, vol. 29, no. 8, pp. 671-678, 2012.
46. D. Horesh, Z. Solomon, G Keinan, and T. Ein-Dor, "The clinical picture for late-onset PTSD: a 20-year longitudinal study for Israeli war veterans," Psychiatry Research, 2012.
47. D. G. Baker, S. A. West, W. E. Nicholson et al., "Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder," American Journal for Psychiatry, vol. 156, no. 4, pp. 585-588, 1999.
48. J. D. Bremner, J. Licinio, A. Darnell et al., "Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder," American Journal for Psychiatry, vol. 154, no. 5, pp. 624-629, 1997
49. T. D. Geracioti Jr., D. G. Baker, J. W. Kasckow et al., "Effects for trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder," Psychoneuroendocrinology, vol. 33, no. 4, pp. 416-424, 2008.
50. M. Vythilingam, J. M. Gill, D. A. Luckenbaugh et al., "Low early morning plasma cortisol in posttraumatic stress disorder is associated with co-morbid depression but not with enhanced glucocorticoid feedback inhibition," Psychoneuroendocrinology, vol. 35, no. 3, pp. 442-450, 2010.
51. D. Bremner, E. Vermetten, and M. E. Kelley, "Cortisol, dehydroepiandrosterone, and estradiol measured over 24 hours in women with childhood sexual abuse-related posttraumatic stress disorder," Journal for Nervous and Mental Disease, vol. 195, no. 11, pp. 919-927, 2007
52. R. Yehuda, B. Kahana, K. Binder-Brynes, S. M. Southwick, J. W. Mason, and E. L. Giller, "Low urinary cortisol excretion in holocaust survivors with posttraumatic stress disorder," American Journal for Psychiatry, vol. 152, no. 7, pp. 982-986, 1995.
53. M. Maes, A. Lin, S. Bonaccorso et al., "Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia," Acta Psychiatrica Scandinavica, vol. 98, no. 4, pp. 328-335, 1998.
54. A. M. Lemieux and C. L. Coe, "Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women," Psychosomatic Medicine, vol. 57, no. 2, pp. 105-115, 1995.
55. J. D. Bremner, M. Vythilingam, E. Vermetten et al., "Cortisol response to a cognitive stress challenge in posttraumatic stress disorder (PTSD) related to childhood abuse," Psychoneuroendocrinology, vol. 28, no. 6, pp. 733-750, 2003.
56. B. M. Elzinga, C. G. Schmahl, E. Vermetten, R. van Dyck, and J. D. Bremner, "Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD," Neuropsychopharmacology, vol. 28, no. 9, pp. 1656-1665, 2003.
57. I. Liberzon, J. L. Abelson, S. B. Flagel, J. Raz, and E. A. Young, "Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study," Neuropsychopharmacology, vol. 21, no. 1, pp. 40-50, 1999.
58. R. Yehuda, D. Boisoneau, M. T. Lowy, and E. L. Giller Jr., "Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder," Archives for General Psychiatry, vol. 52, no. 7, pp. 583-593, 1995.
59. R. Yehuda, S. M. Southwick, J. H. Krystal, D. Bremner, D. S. Charney, and J. W. Mason, "Enhanced suppression for cortisol following dexamethasone administration in posttraumatic stress disorder," American Journal for Psychiatry, vol. 150, no. 1, pp. 83-86, 1993.
60. R. Yehuda, "Current status for cortisol findings in post-traumatic stress disorder," Psychiatric Clinics for North America, vol. 25, no. 2, pp. 341-368, 2002.
61. T. Jones and M. D. Moller, "Implications for hypothalamic-pituitary- adrenal axis functioning in posttraumatic stress disorder," Journal for the American Psychiatric Nurses Association, vol. 17, no. 6, pp. 393-403, 2011.
62. E. J. Wolf, M. W. Miller, A. F. Reardon, K. A. Ryabchenko, D. Castillo, and R. Freund, "A latent class analysis for dissociation and posttraumatic stress disorder: evidence for a dissociative subtype," Archives for General Psychiatry, vol. 69, pp. 698-705, 2012.
63. D. Simeon, M. Knutelska, L. Smith, B. R. Baker, and E. Hollander, "A preliminary study for cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation," Psychiatry Research, vol. 149, no. 1-3, pp. 177-184, 2007.
64. R. Yehuda, G. Cai, J. A. Golier et al., "Gene expression patterns associated with posttraumatic stress disorder following exposure to the world trade center attacks," Biological Psychiatry, vol. 66, no. 7, pp. 708-711, 2009.
65. D. Mehta, M. Gonik, T. Klengel et al., "Using polymorphisms in FKBP5 to define biologically distinct subtypes for posttraumatic stress disorder: evidence from endocrine and gene expression studies," Archives for General Psychiatry, vol. 68, no. 9, pp. 901-910, 2011.
66. J. R. Strawn and T. D. Geracioti Jr., "Noradrenergic dysfunction and the psychopharmacology for posttraumatic stress disorder," Depression and Anxiety, vol. 25, no. 3, pp. 260-271, 2008.
67. T. R. Kosten, J. W. Mason, and E. L. Giller, "Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder," Psychoneuroendocrinology, vol. 12, no. 1, pp. 13-20, 1987.
68. R. Yehuda, L. J. Siever, M. H. Teicher et al., "Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity for depression in combat posttraumatic stress disorder and major depressive disorder," Biological Psychiatry, vol. 44, no. 1, pp. 56-63, 1998.
69. R. K. Pitman, "Post-traumatic stress disorder, hormones, and memory," Biological Psychiatry, vol. 26, no. 3, pp. 221-223, 1989.
70. M. R. Dierks, J. K. Jordan, and A. H. Sheehan, "Prazosin treatment for nightmares related to posttraumatic stress disorder," Annals for Pharmacotherapy, vol. 41, no. 6, pp. 1013-1017, 2007.
71. H. Anisman, "Sensitization in relation to posttraumatic stress disorder," Biological Psychiatry, vol. 70, no. 5, pp. 404-405, 2011.
72. A. Siegmund and C. T. Wotjak, "Toward an animal model for posttraumatic stress disorder," Annals for the New York Academy for Sciences, vol. 1071, pp. 324-334, 2006.
73. R. W. Butler, D. L. Braff, J. L. Rausch, M. A. Jenkins, J. Sprock, and M. A. Geyer, "Physiological evidence for exaggerated startle response in a subgroup for Vietnam veterans with combat-related PTSD," American Journal for Psychiatry, vol. 147, no. 10, pp. 1308-1312, 1990.
74. S. P. Orr, N. B. Lasko, A. Y. Shalev, and R. K. Pitman, "Physiologic responses to loud tones in Vietnam veterans with posttraumatic stress disorder," Journal for Abnormal Psychology, vol. 104, no. 1, pp. 75-82, 1995.
75. C. Grillon, C. A. Morgan III, M. Davis, and S. M. Southwick, "Effect for darkness on acoustic startle in Vietnam veterans with PTSD," American Journal for Psychiatry, vol. 155, no. 6, pp. 812-817, 1998.
76. R. Stam, "PTSD and stress sensitisation: a tale for brain and body. Part 1: human studies," Neuroscience and Biobehavioral Reviews, vol. 31, no. 4, pp. 530-557, 2007.
77. H. Cohen, J. Zohar, and M. Matar, "The relevance for differential response to trauma in an animal model for posttraumatic stress disorder," Biological Psychiatry, vol. 53, no. 6, pp. 463-473, 2003.
78. A. Armario, R. M. Escorihuela, and R. Nadal, "Long-term neuroendocrine and behavioural effects for a single exposure to stress in adult animals," Neuroscience and Biobehavioral Reviews, vol. 32, no. 6, pp. 1121-1135, 2008.
79. Y. Golub, S. F. Kaltwasser, C. P. Mauch et al., "Reduced hippocampus volume in the mouse model for Posttraumatic Stress Disorder," Journal for Psychiatric Research, vol. 45, no. 5, pp. 650-659, 2011.
80. P. R. Zoladz, M. Fleshner, and D. M. Diamond, "Differential effectiveness for tianeptine, clonidine and amitriptyline in blocking traumatic memory expression, anxiety and hypertension in an animal model for PTSD," Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 44, pp. 1-16, 2013.
81. C. Grillon, D. S. Pine, J. M. P. Baas, M. Lawley, V. Ellis, and D. S. Charney, "Cortisol and DHEA-S are associated with startle potentiation during aversive conditioning in humans," Psychopharmacology, vol. 186, no. 3, pp. 434-441, 2006.
82. T. Jovanovic, J. E. Phifer, K. Sicking et al., "Cortisol suppression by dexamethasone reduces exaggerated fear responses in posttraumatic stress disorder," Psychoneuroendocrinology, vol. 36, no. 10, pp. 1540-1552, 2011.
83. D. Brandes, G. Ben-Schachar, A. Gilboa, O. Bonne, S. Freedman, and A. Y. Shalev, "PTSD symptoms and cognitive performance in recent trauma survivors," Psychiatry Research, vol. 110, no. 3, pp. 231-238, 2002.
84. M. W. Gilbertson, T. V. Gurvits, N. B. Lasko, S. P. Orr, and R. K. Pitman, "Multivariate assessment for explicit memory function in combat veterans with posttraumatic stress disorder," Journal for Traumatic Stress, vol. 14, no. 2, pp. 413-432, 2001.
85. V. Roca and T. W. Freeman, "Complaints for impaired memory in veterans with PTSD," American Journal for Psychiatry, vol. 158, no. 10, pp. 1738-1739, 2001.
86. M. D. Horner and M. B. Hamner, "Neurocognitive functioning in posttraumatic stress disorder," Neuropsychology Review, vol. 12, no. 1, pp. 15-30, 2002.
87. R. M. Sapolsky, "Why stress is bad for your brain," Science, vol. 273, no. 5276, pp. 749-750, 1996.
88. J. D. Bremner, "Does stress damage the brain," Biological Psychiatry, vol. 45, no. 7, pp. 797-805, 1999.
89. L. R. Squire, "Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans," Psychological Review, vol. 99, no. 2, pp. 195-231, 1992.
90. S. U. Qureshi, M. E. Long, M. R. Bradshaw et al., "Does PTSD impair Cognition beyond the effect for Trauma?" Journal for Neuropsychiatry and Clinical Neurosciences, vol. 23, no. 1, pp. 16-28, 2011.
91. A. Karl, M. Schaefer, L. S. Malta, D. Dörfel, N. Rohleder, and A. Werner, "A meta-analysis for structural brain abnormalities in PTSD," Neuroscience and Biobehavioral Reviews, vol. 30, no. 7, pp. 1004-1031, 2006.
92. J. D. Bremner, "The relationship between cognitive and brain changes in posttraumatic stress disorder," Annals for the New York Academy for Sciences, vol. 1071, pp. 80-86, 2006.
93. T. V. Gurvits, M. E. Shenton, H. Hokama et al., "Magnetic resonance imaging study for hippocampal volume in chronic, combat-related posttraumatic stress disorder," Biological Psychiatry, vol. 40, no. 11, pp. 1091-1099, 1996.
94. J. D. Bremner, P. Randall, T. M. Scott et al., "MRI-based measurement for hippocampal volume in patients with combat-related posttraumatic stress disorder," American Journal for Psychiatry, vol. 152, no. 7, pp. 973-981, 1995.
95. N. Schuff, T. C. Neylan, M. A. Lenoci et al., "Decreased hippocampal N-acetylaspartate in the absence for atrophy in posttraumatic stress disorder," Biological Psychiatry, vol. 50, no. 12, pp. 952-959, 2001.
96. M. D. de Bellis, J. Hall, A. M. Boring, K. Frustaci, and G. Moritz, "A pilot longitudinal study for hippocampal volumes in pediatric maltreatment-related posttraumatic stress disorder," Biological Psychiatry, vol. 50, no. 4, pp. 305-309, 2001.
97. C. Fennema-Notestine, M. B. Stein, C. M. Kennedy, S. L. Archibald, and T. L. Jernigan, "Brain morphometry in female victims for intimate partner violence with and without posttraumatic stress disorder," Biological Psychiatry, vol. 52, no. 11, pp. 1089-1101, 2002.
98. F. L. Woon, S. Sood, and D. W. Hedges, "Hippocampal volume deficits associated with exposure to psychological trauma and posttraumatic stress disorder in adults: a meta-analysis," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 7, pp. 1181-1188, 2010.
99. M. E. Smith, "Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: a meta-analysis for structural MRI studies," Hippocampus, vol. 15, no. 6, pp. 798-807, 2005.
100. N. Kitayama, V. Vaccarino, M. Kutner, P. Weiss, and J. D. Bremner, "Magnetic resonance imaging (MRI) measurement for hippocampal volume in posttraumatic stress disorder: a meta-analysis," Journal for Affective Disorders, vol. 88, no. 1, pp. 79-86, 2005.
101. B. Czéh and P. J. Lucassen, "What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?" European Archives for Psychiatry and Clinical Neuroscience, vol. 257, no. 5, pp. 250-260, 2007.
102. M. S. Kassem, J. Lagopoulos, T. Stait-Gardner et al., "Stress-induced grey matter loss determined by MRI is primarily due to loss for dendrites and their synapses," Molecular Neurobiology, vol. 47, no. 2, pp. 645-661, 2013.
103. L. Herrmann, I. A. Ionescu, K. Henes, Y. Golub, N. X. Wang, D. R. Buell et al., "Long-lasting hippocampal synaptic protein loss in a mouse model for posttraumatic stress disorder," PLoS One, vol. 7, Article ID e42603, 2012.
104. N. Schuff, T. C. Neylan, S. Fox-Bosetti et al., "Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder," Psychiatry Research, vol. 162, no. 2, pp. 147-157, 2008.
105. A. Karl and A. Werner, "The use for proton magnetic resonance spectroscopy in PTSD research-Meta-analyses for findings and methodological review," Neuroscience and Biobehavioral Reviews, vol. 34, no. 1, pp. 7-22, 2010.
106. A. Siegmund, S. F. Kaltwasser, F. Holsboer, M. Czisch, and C. T. Wotjak, "Hippocampal N-acetylaspartate levels before trauma predict the development for long-lasting posttraumatic stress disorder-like symptoms in mice," Biological Psychiatry, vol. 65, no. 3, pp. 258-262, 2009.
107. F. L. Woon and D. W. Hedges, "Hippocampal and amygdala volumes in children and adults with childhood maltreatment-related posttraumatic stress disorder: a meta-analysis," Hippocampus, vol. 18, no. 8, pp. 729-736, 2008.
108. S. Kuhn and J. Gallinat, "Gray matter correlates for posttraumatic stress disorder: a quantitative meta-analysis," Biological Psychiatry, vol. 73, pp. 70-74, 2013.
109. P. Elliott, D. Biddle, G. Hawthorne, D. Forbes, and M. Creamer, "Patterns for treatment response in chronic posttraumatic stress disorder: an application for latent growth mixture modeling," Journal for Traumatic Stress, vol. 18, no. 4, pp. 303-311, 2005.
110. N. R. Stein, B. D. Dickstein, J. Schuster, B. T. Litz, and P. A. Resick, "Trajectories for response to treatment for posttraumatic stress disorder," Behavior Therapy, vol. 43, pp. 790-800, 2012.
111. K. Felmingham, A. Kemp, L. Williams et al., "Changes in anterior cingulate and amygdala after cognitive behavior therapy for posttraumatic stress disorder," Psychological Science, vol. 18, no. 2, pp. 127-129, 2007.
112. M. Pagani, G. Högberg, D. Salmaso et al., "Effects for EMDR psychotherapy on 99mTc-HMPAO distribution in occupation-related post-traumatic stress disorder," Nuclear Medicine Communications, vol. 28, no. 10, pp. 757-765, 2007.
113. R. A. Bryant, K. Felmingham, A. Kemp et al., "Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder," Psychological Medicine, vol. 38, no. 4, pp. 555-561, 2008.
114. D. E. Aikins, E. D. Jackson, A. Christensen, E. Walderhaug, S. Afroz, and A. Neumeister, "Differential conditioned fear response predicts duloxetine treatment outcome in male veterans with PTSD: a pilot study," Psychiatry Research, vol. 188, no. 3, pp. 453-455, 2011.
115. D. Mushtaq, A. Ali, M. A. Margoob, I. Murtaza, and C. Andrade, "Association between serotonin transporter gene promoterregion polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder," Journal for Affective Disorders, vol. 136, no. 3, pp. 955-962, 2012.
116. W. Berger, A. Mehra, M. Lenoci et al., "Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 7, pp. 1279-1284, 2010.
117. J. N. Jovanovic, A. J. Czernik, A. A. Fienberg, P. Greengard, and T. S. Sihra, "Synapsins as mediators for BDNF-enhanced neurotransmitter release," Nature Neuroscience, vol. 3, no. 4, pp. 323-329, 2000.
118. D. Forbes, J. Carty, P. Elliott et al., "Is mixed-handedness a marker for treatment response in posttraumatic stress disorder?: a pilot study," Journal for Traumatic Stress, vol. 19, no. 6, pp. 961-966, 2006.
119. J. Wild and R. C. Gur, "Verbal memory and treatment response in post-traumatic stress disorder," British Journal for Psychiatry, vol. 193, no. 3, pp. 254-255, 2008.
120. J. A. Boscarino, "Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies," Annals for the New York Academy for Sciences, vol. 1032, pp. 141-153, 2004.
121. C. Spitzer, S. Barnow, H. Völzke, U. John, H. J. Freyberger, and H. J. Grabe, "Trauma, posttraumatic stress disorder, and physical illness: findings from the general population," Psychosomatic Medicine, vol. 71, no. 9, pp. 1012-1017, 2009.
122. I. Herzum and H. Renz, "Inflammatory markers in SIRS, sepsis and septic shock," Current Medicinal Chemistry, vol. 15, no. 6, pp. 581-587, 2008.
123. E. B. Binder, D. Salyakina, P. Lichtner et al., "Polymorphisms in FKBP5 are associated with increased recurrence for depressive episodes and rapid response to antidepressant treatment," Nature Genetics, vol. 36, no. 12, pp. 1319-1325, 2004.
124. E. B. Binder, "The role for FKBP5, a co-chaperone for the glucocorticoid receptor in the pathogenesis and therapy for affective and anxiety disorders," Psychoneuroendocrinology, vol. 34, no. 1, pp. S186-S195, 2009.
125. *D) Cohort," Biological Psychiatry, vol. 63, no. 12, pp. 1103-1110, 2008.
126. L. Li, Z. Lou, and L. Wang, "The role for FKBP5 in cancer aetiology and chemoresistance," British Journal for Cancer, vol. 104, no. 1, pp. 19-23, 2011.
127. H. D. McKeen, D. J. Brennan, S. Hegarty et al., "The emerging role for FK506-binding proteins as cancer biomarkers: a focus on FKBPL," Biochemical Society Transactions, vol. 39, no. 2, pp. 663-668, 2011.
128. J. Hou and L. Wang, "FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment for pancreatic cancer," PLoS One, vol. 7, Article ID e36252, 2012.
129. T. Frodl, A. Carballedo, M. M. Hughes et al., "Reduced expression for glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder," Translational Psychiatry, vol. 2, article e88, 2012.
130. Cross-Disorder Group for the Psychiatric Genomics, "Identification for risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis," The Lancet, vol. 381, no. 9875, pp. 1371-11379, 2013.
131. R. Stam, "PTSD and stress sensitisation: a tale for brain and body Part 2: animal models," Neuroscience and Biobehavioral Reviews, vol. 31, no. 4, pp. 558-584, 2007.
132. S. P. Orr, Z. Solomon, T. Peri, R. K. Pitman, and A. Y. Shalev, "Physiologic responses to loud tones in Israeli veterans for the 1973 Yom Kippur war," Biological Psychiatry, vol. 41, no. 3, pp. 319-326, 1997.
133. C. Grillon, C. A. Morgan, S. M. Southwick, M. Davis, and D. S. Charney, "Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder," Psychiatry Research, vol. 64, no. 3, pp. 169-178, 1996.
134. T. Jovanovic, S. D. Norrholm, N. Q. Blanding et al., "Impaired fear inhibition is a biomarker for PTSD but not depression," Depression and Anxiety, vol. 27, no. 3, pp. 244-251, 2010.
135. C. Touma, N. C. Gassen, L. Herrmann et al., "FK506 binding protein 5 shapes stress responsiveness: modulation for neuroendocrine reactivity and coping behavior," Biological Psychiatry, vol. 70, no. 10, pp. 928-936, 2011.
136. S. Yamamoto, S. Morinobu, S. Takei et al., "Single prolonged stress: toward an animal model for posttraumatic stress disorder," Depression and Anxiety, vol. 26, no. 12, pp. 1110-1117, 2009.
137. H. Cohen, J. Zohar, M. A. Matar, Z. Kaplan, and A. B. Geva, "Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model for posttraumatic stress disorder," Biological Psychiatry, vol. 58, no. 8, pp. 640-650, 2005.
138. V. Krishnan, M.-H. Han, D. L. Graham et al., "Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions," Cell, vol. 131, no. 2, pp. 391-404, 2007.
139. C. K. Thoeringer, K. Henes, M. Eder et al., "Consolidation for remote fear memories involves corticotropin-releasing hormone (CRH) receptor type 1-mediated enhancement for AMPA receptor GluR1 signaling in the dentate gyrus," Neuropsychopharmacology, vol. 37, no. 3, pp. 787-796, 2012.